Livzon Pharmaceutical Group Inc (000513.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE0000002Y8
Livzon Pharmaceutical Group Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 11.81 bn CNY | 11.91 bn CNY |
| Gross profit | 7.56 bn CNY | 7.63 bn CNY |
| Operating income | 2.84 bn CNY | 2.62 bn CNY |
| EBIT | 2.54 bn CNY | 2.62 bn CNY |
| Net income | 2.06 bn CNY | 2.02 bn CNY |
| Diluted EPS – continuing operations | 2.24 CNY | 2.27 CNY |
Full history since 1991, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Livzon Pharmaceutical Group Inc
Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and internationally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field; Ilaprazole enteric-coated tablets, ilaprazole sodium for injection, and bismuth potassium citrate products for the gastrointestinal field; fluvoxamine maleate for the psychiatric and neurological field; and shenqi fuzheng injection and anti-viral granules for the traditional Chinese medicine field. It also produces APIs and intermediates, such as mevastatin, acarbose, teicoplanin, gentamycin sulfate, phenylalanine, vancomycin hydrochloride, daptomycin, milbemycin oxime, and ceftriaxone sodium, as well as diagnostic reagents such as diagnostic kits for IgM antibody to mycoplasma pneumonia; diagnostic kits for human immunodeficiency virus antibody; and livzon antinuclear antibody test kits. In addition, the company offers nucleic acid test kits; livzon interferon-gamma release assays test kits; influenza A/B virus antigen detection kits; and treponema pallidum antibody detection kits. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, stomatitis granules, biochemical and polypeptide APIs, and antibiotic APIs, as well as diagnostic equipment. Livzon Pharmaceutical Group Inc. was incorporated in 1985 and is headquartered in Zhuhai, China.
More stocks
- Jb Financial (175330.KS)
- Guotai Junan International Holdings Ltd (1788.HK)
- XJ Electric Co Ltd (000400.SZ)
- Minor International Public Company Limited (MINT.BK)
- Fujian Longking Co Ltd (600388.SS)
- SL GREEN REALTY CORP (SLG)
- Alten SA (ATE.PA)
- Shaftesbury Capital PLC (SHC.L)
- Sino-American Silicon Products (5483.TWO)
- Nichirei Corp (2871.T)
- SEB SA (SK.PA)
- Cipher Digital Inc. (CIFR)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.